Pulmonary hypertension in chronic lung disease and hypoxia
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Pulmonary hypertension (PH) frequently complicates the course of patients with various forms of chronic lung disease (CLD). CLD-associated PH (CLD-PH) is invariably associated with reduced functional ability, impaired quality of life, greater oxygen requirements and an increased risk of mortality. The aetiology of CLD-PH is complex and multifactorial, with differences in the pathogenic sequelae between the diverse forms of CLD. Haemodynamic evaluation of PH severity should be contextualised within the extent of the underlying lung disease, which is best gauged through a combination of physiological and imaging assessment. Who, when, if and how to screen for PH will be addressed in this article, as will the current state of knowledge with regard to the role of treatment with pulmonary vasoactive agents. Although such therapy cannot be endorsed given the current state of findings, future studies in this area are strongly encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The OPTN/UNOS registry data demonstrate that Group 3 pulmonary hypertension is common in patients with advanced CF, ILD, and COPD and is associated with increased oxygen requirements and increased mortality.(294–299)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [294]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Self-citationSildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Self-citationSevere Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714
Pulmonary Hypertension in Chronic Lung Diseases
Seeger, W., Adir, Y., Barberà, J. A., Champion, H., Coghlan, J. G., Cottin, V., De Marco, T., Galiè, N., Ghio, S., Gibbs, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.036 · Cited by 673
Self-citationA Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634
Consensus Statement on Chronic and Subacute High Altitude Diseases
León-Velarde, F., Maggiorini, M., Reeves, J. T., Aldashev, A., Asmus, I., Bernardi, L., Ge, R.-L., Hackett, P., Kobayashi, T., Moore, L. G., et al. (2005) · High Altitude Medicine & Biology · doi:10.1089/ham.2005.6.147 · Cited by 630
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Self-citationKESSLER, R., FALLER, M., FOURGAUT, G., MENNECIER, B., & WEITZENBLUM, E. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9803117 · Cited by 549
Obesity-Associated hypoventilation in hospitalized patients: prevalence, effects, and outcome
Nowbar, S., Burkart, K. M., Gonzales, R., Fedorowicz, A., Gozansky, W. S., Gaudio, J. C., Taylor, M. R. G., & Zwillich, C. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.022 · Cited by 512
Clinical features of paediatric pulmonary hypertension: a registry study
Berger, R. M., Beghetti, M., Humpl, T., Raskob, G. E., Ivy, D. D., Jing, Z.-C., Bonnet, D., Schulze-Neick, I., & Barst, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61621-8 · Cited by 508
Cited by
Items 101–200 of 834
Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD
Miravitlles, M., Rubio, M. C., Molina, J., Almagro, P., Gómez, J.-T., Trigueros, J. A., Sánchez-Angarita, E., Cosío, B. G., Casanova, C., López-Campos, J. L., et al. (2025) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2025.10.008 · Cited by 41
Therapeutic potential of plant-derived tannins in non-malignant respiratory diseases
Rajasekaran, S., Rajasekar, N., & Sivanantham, A. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108632 · Cited by 41
Dwivedi, K., Sharkey, M. J., Condliffe, R. A., Uthoff, J., Alabed, S., Metherall, P., Lu, H., Wild, J. M., Hoffman, E. A., Swift, A. J., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11040679 · Cited by 41
Evaluation, Diagnosis, and Classification of Pulmonary Hypertension
Beshay, S. M., Guha, A., & Sahay, S. (2021) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/ocdf4453 · Cited by 41
Pulmonary Hypertension in the Context of Heart Failure With Preserved Ejection Fraction
Inampudi, C., Silverman, D. N., Simon, M. A. M., Leary, P. J., Sharma, K., Houston, B. A., Vachiéry, J., Haddad, F., & Tedford, R. J. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.08.039 · Cited by 41
Nathan, S. D., Cottin, V., Behr, J., Hoeper, M. M., Martínez, F. J., Corte, T. J., KEOGH, A. M., Leuchte, H. H., Moğulkoç, N., Ulrich, S., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.02.006 · Cited by 40
Self-citationPulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment
Behr, J., & Nathan, S. D. (2021) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000790 · Cited by 40
Self-citationTorres‐Castro, R., Gimeno‐Santos, E., Vilaró, J., Figuls, M. R. I., Moisés, J., Vasconcello‐Castillo, L., Franco, T. O., Barberà, J. A., & Blanco, I. (2021) · European Respiratory Review · doi:10.1183/16000617.0321-2020 · Cited by 39
Louw, E. H., Baines, N., Maarman, G. J., Osman, M., Sigwadhi, L. N., Irusen, E. M., Koegelenberg, C. F. N., Doubell, A. F., Nathan, S. D., Channick, R. N., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12184 · Cited by 39
Self-citationEurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023)
Chazova, I. E., Martynyuk, T. V., Shmalts, A. A., Владимирович, Г. В., Danilov, N. M., Veselova, T. N., Захаровна, К. И., Шогаибович, С. А., Стукалова, О. В., Азизов, В. А., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-1-6-85 · Cited by 38
Ilonze, O. J., Ebong, I., Guglin, M. E., Nair, A., Rich, J., McLaughlin, V., Tedford, R. J., & Mazimba, S. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2024.04.031 · Cited by 37
Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets
Nisar, A., Khan, S., Li, W., Hu, L., Samarawickrama, P. N., Gold, N. M., Zi, M., Mehmood, S. A., Miao, J., & He, Y. (2024) · MedComm · doi:10.1002/mco2.786 · Cited by 37
Group 3 pulmonary hypertension: Challenges and opportunities
McGetterick, M., & Peacock, A. J. (2020) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2020.6 · Cited by 37
Self-citationYuan, R., Liu, M., Cheng, Y., Fang, Y., Zhu, X., Zhou, S., & Dong, M. (2023) · ACS Nano · doi:10.1021/acsnano.2c12190 · Cited by 37
Weatherald, J. C., Nathan, S. D., El‐Kersh, K., Argula, R. G., DuBrock, H. M., Rischard, F. P., Cassady, S. J., Tarver, J., Levine, D. J., Tapson, V. F., et al. (2024) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-002116 · Cited by 36
Self-citationClinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis
Alhamad, E., Cal, J. G., Alrajhi, N. N., Aharbi, W., Al-Rikabi, A. R. D. A. C., & AlBoukai, A. (2020) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_230_20 · Cited by 36
Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
Copeland, C. R., & LANCASTER, L. H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.743977 · Cited by 35
Wang, M., Li, X., & Chen, L. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105536 · Cited by 35
Gaikwad, A. V., Lu, W., Dey, S., Bhattarai, P., Haug, G., Larby, J., Chia, C., Jaffar, J., Westall, G. P., Singhera, G. K., et al. (2023) · ERJ Open Research · doi:10.1183/23120541.00487-2022 · Cited by 35
Molecular and functional imaging insights into the role of hypoxia in cancer aggression
Kakkad, S. M., Krishnamachary, B., Jacob, D., Pacheco‐Torres, J., Goggins, E. S., Bharti, S. K., Penet, M., & Bhujwalla, Z. M. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09788-3 · Cited by 35
Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia
Nakamura, K., Akagi, S., Ejiri, K., Taya, S., Saito, Y., Kuroda, K., Takaya, Y., Toh, N., Nakayama, R., Katanosaka, Y., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020835 · Cited by 34
Pulmonary arterial hypertension
Luna‐López, R., Martín, A. R., & Subías, P. E. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.05.010 · Cited by 33
IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis
Milara, J., Roger, I., Montero, P., Artigues, E., Escrivá, J., & Cortijo, J. (2022) · Respiratory Research · doi:10.1186/s12931-022-02241-0 · Cited by 33
The role of lactate metabolism and lactylation in pulmonary arterial hypertension
Peng, T.-Y., Lu, J., Zheng, X.-L., Zeng, C. C., & He, Y. (2025) · Respiratory Research · doi:10.1186/s12931-025-03163-3 · Cited by 32
Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia: A Review
Varghese, N. P., & Rios, D. R. (2019) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2018.0984 · Cited by 32
Pulmonary Complications in Cystic Fibrosis: Past, Present, and Future
Mingora, C. M., & Flume, P. A. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.017 · Cited by 32
Arslan, A., Smith, J., Qureshi, M. R., Uysal, A., Patel, K., Herazo‐Maya, J. D., & Bandyopadhyay, D. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1306032 · Cited by 32
Association Between Systemic and Pulmonary Vascular Dysfunction in COPD
Piccari, L., del Pozo, R., Blanco, I., García-Lucio, J., Torralba, Y., Tura-Ceide, O., Moisés, J., Sitges, M., Peinado, V. I., & Barberà, J. A. (2020) · International Journal of COPD · doi:10.2147/copd.s257679 · Cited by 32
Myronenko, O., Foris, V., Crnkovic, S., Olschewski, A., Rocha, S., Nicolls, M., & Olschewski, H. (2023) · European Respiratory Review · doi:10.1183/16000617.0173-2022 · Cited by 29
Self-citationProgress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
Nathan, S. D. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202212-2342ci · Cited by 31
Self-citationPulmonary hypertension and chronic lung disease: where are we headed?
Elia, D., Caminati, A., Zompatori, M., Cassandro, R., Lonati, C., Luisi, F., Pelosi, G., Provencher, S., & Harari, S. A. (2019) · European Respiratory Review · doi:10.1183/16000617.0065-2019 · Cited by 31
Self-citationIdiopathic pulmonary arterial hypertension and co‐existing lung disease: is this a new phenotype?
Peacock, A. J., Ling, Y., Johnson, M., Kiely, D. G., Condliffe, R. A., Elliot, C. A., Gibbs, J. S. R., Howard, L., Pepke‐Żaba, J., Sheares, K. K. K., et al. (2020) · Pulmonary Circulation · doi:10.1177/2045894020914851 · Cited by 31
Self-citationTello, K., Yogeswaran, A., Majeed, R. W., Kiely, D. G., Lawrie, A., Brittain, E. L., Annis, J. S., Olschewski, H., Kovács, G., Hassoun, P. M., et al. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.08.016 · Cited by 30
Self-citationLoss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
Heukels, P., Corneth, O. B. J., van Uden, D., van Hulst, J. A. C., van den Toorn, L. M., van den Bosch, A. E., Wijsenbeek, M. S., Boomars, K. A., Kool, M., & Hendriks, R. W. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215460 · Cited by 30
Gredic, M., Wu, C., Hadžić, S., Pak, O., Savai, R., Kojonazarov, B. K., Doswada, S., Weiß, A., Weigert, A., Günther, A., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01153-2021 · Cited by 29
Self-citationLinee guida ESC/ERS 2022 per la diagnosi e il trattamento dell’ipertensione polmonare
Humbert, M. J. C., Kovács, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Subías, P. E., Ferrari, P., et al. (2023) · Giornale italiano di cardiologia · doi:10.1714/4014.39906 · Cited by 29
Self-citationInsights into the relationship between serum uric acid and pulmonary hypertension (Review)
Zhou, Y., Chen, M., Zheng, J. J., Shui, X., He, Y. Z., Luo, H., & Lei, W. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13133 · Cited by 29
Eul, B. G., Cekay, M., Pullamsetti, S. S., Tello, K., Wilhelm, J., Gattenlöhner, S., Sibelius, U., Grimminger, F., Seeger, W., & Savai, R. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-2023le · Cited by 28
Self-citationdel Castillo, A. G., López‐Meseguer, M., Fonollosa‐Pla, V., Sáez, B., Colunga-Argüelles, D., Revilla‐López, E., Rubio‐Rivas, M., Ropero, M. J. C., Argibay, A. B., Barberà, J. A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09353-z · Cited by 27
Rivière, A., Picard, C., Berastegui, C., Cuesta, V. M. M., Bunel, V., Godinas, L., Salvaterra, E., Rossetti, V., Savale, L., Israël‐Biet, D., et al. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17177 · Cited by 27
The PH‐ILD Detection tool: External validation and use in patients with ILD
Parikh, R., O’Sullivan, D. M., & Farber, H. W. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12273 · Cited by 27
Ruffenach, G., Umar, S., Vaillancourt, M., Hong, J. S., Cao, N., Sarji, S., Moazeni, S., Cunningham, C. M., Ardehali, A. A., Reddy, S. T., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810061 · Cited by 27
Cottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.01.005 · Cited by 27
DuBrock, H. M., Nathan, S. D., Reeve, B. B., Kolaitis, N. A., Mathai, S. C., Classi, P. M., Nelsen, A. C., Olayinka‐Amao, B., Norcross, L., & Martin, S. A. (2021) · Pulmonary Circulation · doi:10.1177/20458940211005641 · Cited by 26
Self-citationShlobin, O. A., Shen, E., Wort, S. J., Piccari, L., Scandurra, J., Hassoun, P. M., Nikkho, S. M., & Nathan, S. D. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12310 · Cited by 26
Self-citationWats, K., Rodríguez, D., Prins, K. W., Sadiq, A., Fogel, J., Goldberger, M. J., Moskovits, M., Tootkaboni, M. P., Shani, J., & Jacob, J. (2021) · Pulmonary Circulation · doi:10.1177/20458940211007040 · Cited by 26
Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension
Bordag, N., Nagy, B. M., Zügner, E., Ludwig, H., Foris, V., Nagaraj, C., Biasin, V., Kovács, G., Kneidinger, N., Bodenhofer, U., et al. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202407-1345oc · Cited by 25
Self-citationChang, S., Wu, J., Jin, J., Shi, H., Gao, R., Li, X., Jia, D., Sun, X., Ou, T., Yang, J., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2555476 · Cited by 25
Xing, Y., Qi, J., Cheng, X., Song, X., Zhang, J., Li, S., Zhao, X., Gong, T., Yang, J., Zhao, C., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028299 · Cited by 25
Zeder, K., Marsh, L. M., Avian, A., Brčić, L., Birnhuber, A., Douschan, P., Foris, V., Sassmann, T., Höetzenecker, K., Boehm, P. M., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.02.1044 · Cited by 25
Self-citationBioinformatics analysis of hypoxia associated genes and inflammatory cytokine profiling in COPD-PH
Choudhury, P., Dasgupta, S., Kar, A., Sarkar, S., Chakraborty, P., Bhattacharyya, P., Roychowdhury, S., & Chaudhury, K. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107658 · Cited by 25
Atrial arrhythmias in chronic lung disease‐associated pulmonary hypertension
Vahdatpour, C., Luebbert, J. J., & Palevsky, H. I. (2020) · Pulmonary Circulation · doi:10.1177/2045894020910685 · Cited by 25
Sobiecka, M., Lewandowska, K. B., Kober, J., Franczuk, M., Skoczylas, A., Tomkowski, W. Z., Kuś, J., & Szturmowicz, M. (2020) · Lung · doi:10.1007/s00408-020-00346-1 · Cited by 25
Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension
Lahm, T., Hess, E., Barón, A. E., Maddox, T. M., Plomondon, M. E., Choudhary, G., Maron, B. A., Zamanian, R. T., & Leary, P. J. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.09.258 · Cited by 25
Acute exacerbation in interstitial lung disease
Alhamad, E., Cal, J. G., Alrajhi, N. N., & AlBoukai, A. (2021) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_14_21 · Cited by 25
Wu, W., Bonnet, S., Shimauchi, T., Toro, V., Grobs, Y., Romanet, C., Bourgeois, A., Vitry, G., Omura, J., Tremblay, È., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-217377 · Cited by 25
Self-citationCottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100948 · Cited by 25
Litvin, A. Y., Chazova, I. E., Elfimova, E. M., Pevzner, A. V., Poluektov, M. G., Danilov, N. M., Mikhailova, O. O., & Владимировна, А. А. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-3-6-27 · Cited by 24
Emerging role of N6-methyladenosine RNA methylation in lung diseases
Xu, L., Zhou, L., Yan, C., & Li, L. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221128564 · Cited by 24
Kacprzak, A., Tomkowski, W. Z., & Szturmowicz, M. (2023) · Diagnostics · doi:10.3390/diagnostics13142354 · Cited by 24
T-box protein 4mutation causing pulmonary arterial hypertension and lung disease
Maurac, A., Lardenois, É., Eyries, M., Ghigna, M., Petit, I., Montani, D., Guillaumot, A., Caput, B., Chabot, F., & Chaouat, A. (2019) · European Respiratory Journal · doi:10.1183/13993003.00388-2019 · Cited by 24
HACHULLA, E., Launay, D., Boucly, A., Mouthon, L., de Groote, P., Cottin, V., Pugnet, G., Prévôt, G., Bourlier, D., Dauphin, C., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.10.045 · Cited by 24
Chen, X., Hu, F., Chai, F., & Chen, X. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1042 · Cited by 23
Mukherjee, M., Mathai, S. C., Jellis, C. L., Freed, B. H., Yanek, L. R., Agoglia, H. K., Chiu, C., Jani, V., Simpson, C. E., Brittain, E. L., et al. (2024) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.124.017074 · Cited by 23
Zou, R. H., Wallace, W. D., Nouraie, M. S., Chan, S. Y., & Risbano, M. G. (2019) · Pulmonary Circulation · doi:10.1177/2045894019891912 · Cited by 23
Blanco, I., Valeiro, B., Torres‐Castro, R., Barberán-García, A., Torralba, Y., Moisés, J., Sebastián, L., Osorio, J., Ríos, J., Gimeno‐Santos, E., et al. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.10.015 · Cited by 23
Otto-Yáñez, M., Nobrega, A. S. D., Torres-Castro, R., Araújo, P. R., de Farias, C. A. C., de Andrade, A. D., Puppo, H., Resqueti, V., & Fregonezi, G. A. D. F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00537 · Cited by 12
Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease
Choi, J. Y., Song, J. W., & Rhee, C. K. (2022) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2021.0141 · Cited by 22
Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
Haynes, Z. A., Chandel, A., & King, C. S. (2023) · Cells · doi:10.3390/cells12192394 · Cited by 22
Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities
Provencher, S., Mai, V., & Bonnet, S. (2024) · CHEST Journal · doi:10.1016/j.chest.2023.08.023 · Cited by 22
Self-citationRisk assessment in severe pulmonary hypertension due to interstitial lung disease
Yogeswaran, A., Tello, K., Faber, M., Sommer, N., Kuhnert, S., Seeger, W., Grimminger, F., Ghofrani, H. A., Richter, M. J., & Gall, H. J. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.06.014 · Cited by 22
Self-citationPredictors of mortality in interstitial lung disease patients without pulmonary hypertension
Alhamad, E., & Cal, J. G. (2020) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_438_20 · Cited by 22
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification
Oldham, W. M., Hemnes, A. R., Aldred, M. A., Barnard, J., Brittain, E. L., Chan, S. Y., Cheng, F., Cho, M. H., Desai, A. A., Garcia, J. G. N., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.056 · Cited by 22
Management of Connective Tissue Disease-Associated Interstitial Lung Disease
Kawano-Dourado, L. B., & Lee, J. S. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2021.03.010 · Cited by 22
Prevalence of pulmonary hypertension in COPD patients living at high altitude
Aguirre-Franco, C., Torres-Duque, C. A., Salazar, G., Casas, A., Jaramillo, C., & González-García, M. (2022) · Pulmonology · doi:10.1016/j.pulmoe.2021.12.006 · Cited by 21
Combined Pulmonary Fibrosis and Emphysema
Bolaki, M., & Antoniou, K. M. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1708058 · Cited by 21
Glick, M., Baxter, C., López, D., Mufti, K., Sawada, S. G., & Lahm, T. (2020) · Pulmonary Circulation · doi:10.1177/2045894020960967 · Cited by 21
Olschewski, H. (2021) · Diagnostics · doi:10.3390/diagnostics11020311 · Cited by 21
Self-citationImpact of human immunodeficiency virus on pulmonary vascular disease
Kumar, A., Mahajan, A., Salazar, E. A., Pruitt, K., Guzman, C. A., Clauss, M. A., Almodóvar, S., & Dhillon, N. K. (2021) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2021.12 · Cited by 21
Abu, T., Levi, A., Hasdai, D., Kramer, M. R., Bental, T., Bdolah‐Abram, T., Shiyovich, A., Samara, A., Assa, H. V., Perl, L., et al. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02495-y · Cited by 21
Maron, B. A., Choudhary, G., Goldstein, R. L., Garshick, E., Jankowich, M. D., Tucker, T. J. S., LaCerda, K., Hattler, B. G. J., Dempsey, E. C., Sadikot, R. T., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12043 · Cited by 20
Diagnosis and management of pulmonary hypertension related to chronic respiratory disease
Krompa, A., & Marino, P. S. (2022) · Breathe · doi:10.1183/20734735.0205-2022 · Cited by 20
Rosenkranz, S. (2023) · Herz · doi:10.1007/s00059-022-05155-1 · Cited by 20
Wang, Z., Lau, J. W., Liu, S., Ren, Z., Gong, Z., Liu, X., & Xing, B. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202411636 · Cited by 20
Arvanitaki, A., Diller, G., Gatzoulis, M. Α., McCabe, C., Price, L. C., & Wort, S. J. (2024) · European Respiratory Review · doi:10.1183/16000617.0092-2024 · Cited by 20
Respiratory Pathology and Cardiovascular Diseases: A Scoping Review
Campos‐Rodríguez, F., Chiner, E., de la Rosa, D., Cosío, B. G., Hernádez-Hernández, J. R., Jiménez, D., Méndez, R., Molina‐Molina, M., Campos, J. G. S., Vaquero, J. M., et al. (2024) · Open Respiratory Archives · doi:10.1016/j.opresp.2024.100392 · Cited by 20
Rosenkranz, S., Diller, G., Dumitrescu, D., Ewert, R., Ghofrani, H. A., Grünig, E., Halank, M., Held, M., Kaemmerer, H. M., Klose, H. F. E., et al. (2019) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0918-3772 · Cited by 20
Self-citationPulmonary hypertension in majority countries: opportunities amidst challenges
Maarman, G. J., Shaw, J., & Allwood, B. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000702 · Cited by 20
Mamazhakypov, A., Hein, L., & Lother, A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107987 · Cited by 20
Wang, S., Wang, Y., Liu, C., Xu, G., Gao, W., Hao, J.-L., Zhang, M., Wu, G., Yang, Y., Huang, J., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.16949 · Cited by 20
Dwivedi, K., Condliffe, R. A., Sharkey, M. J., Lewis, R. A., Alabed, S., Rajaram, S., Hill, C., Saunders, L. C., Metherall, P., Alandejani, F., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00549-2021 · Cited by 20
Nathan, S. D., Fernandes, P., Psotka, M. A., Vitulo, P., Piccari, L., Antoniou, K., Nikkho, S. M., & Stockbridge, N. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12178 · Cited by 20
Self-citationNon-cardiac Manifestations in Adult Patients With Mucopolysaccharidosis
Stępień, K. M., Bentley, A. M., Chen, C., Dhemech, M. W., Gee, E. C. A., Orton, P. K., Pringle, C., Rajan, J. N., Saxena, A., Tol, G., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.839391 · Cited by 19
Abnormal pulmonary hemodynamics during exercise is associated with exercise capacity in COPD
Sassmann, T., Douschan, P., Foris, V., Tröster, N., Zeder, K., Brčić, L., Tornyos, A., Bachmaier, G., Fuchsjäger, M., Olschewski, H., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02238-9 · Cited by 19
Self-citationMa, L., Wang, Y., Li, X., Wang, Z., Zhang, B., Luo, Y., Wu, Y., Li, Z., & Niu, W. (2023) · Respiratory Research · doi:10.1186/s12931-023-02631-y · Cited by 19
Elkhapery, A. M. R., Hammami, M. B., Sulica, R., Boppana, H., Abdalla, Z., Iyer, C., Taifour, H., Niu, C., & Deshwal, H. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10120498 · Cited by 19
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide
García, A. R., & Piccari, L. (2022) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000890 · Cited by 19
Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition
Calaras, D., Mathioudakis, A. G., Lázár, Z., & Corlăteanu, A. (2023) · Biomedicines · doi:10.3390/biomedicines11061636 · Cited by 18
Lan, C., Fang, G., Qiu, C., Li, X., Yang, F., & Yang, Y. (2023) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2023.2297642 · Cited by 18
Hanley, C., Donahoe, L. L., & Slinger, P. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.11.025 · Cited by 18
Metadata
- Authors
- Nathan, S. D., Barbera, J. A., Gaine, S. P., Harari, S., Martinez, F. J., Olschewski, H., Olsson, K. M., Peacock, A. J., Pepke-Zaba, J., Provencher, S., Weissmann, N., & Seeger, W.
- Affiliations
- Inova Fairfax Hospital (US)
- MultiMedica (IT)
- Medical University of Graz (AT)
- Medizinische Hochschule Hannover (DE)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Justus-Liebig-Universität Gießen (DE)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801914
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351338
- OpenAlex
- W2904463477
- Cited by
- 757
- References
- 94
- Citations by year
- 2026: 54 · 2025: 104 · 2024: 141 · 2023: 96 · 2022: 122 · 2021: 114 · 2020: 76 · 2019: 44
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by-nc)
- Funders
- American Thoracic Society
- Pfizer
- AstraZeneca
- Bayer
- GlaxoSmithKline
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- United Therapeutics Corporation
- Sunovion
- Veracyte
- York University
- National Institutes of Health
- Genentech
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- pulmonary hypertension, chronic lung disease, hypoxia, hemodynamic assessment, quality of life, mortality risk, oxygen requirement
- MeSH terms
- Animals, Hypoxia, Antihypertensive Agents, Chronic Disease, Humans, Hypertension, Pulmonary, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.